Court, Explained
U.S. Federal District Courts
←Back to docket
S.D.N.Y.Procedural orderFiled Sept. 16, 2020

Massachusetts Mutual Life Insurance Company v. Bellini

Judge
Paul Davison
Docket
7:20-cv-00733
Court
U.S. District Court · Southern District of New York
Pages
13
Civil ProcedureDiscovery
In one sentence

In Massachusetts Mutual Life Insurance Company v. Bellini, Judge Davison entered a stipulated protective order governing confidential discovery, including medical, tax, and insurance materials.

Who this affects

Massachusetts Mutual Life Insurance Company, Gabriele Bellini, their counsel and litigation personnel, nonparties producing subpoenaed material, and people who receive confidential documents or information under the protective order.

What happened

Massachusetts Mutual Life Insurance Company v. Bellini concerns a stipulated order governing confidential information exchanged during discovery. The order applies to documents and information designated as confidential, including protected health information, patient files, tax returns, and underwriting or claim-handling materials.

The order limits disclosure of confidential material to specified people and purposes connected to the litigation. It establishes procedures for challenging confidentiality designations, using protected information in depositions and court filings, handling health information, responding to outside legal demands, and returning or destroying protected materials after the litigation.

Judge Davison entered the stipulated protective order on September 16, 2020. The order addresses discovery confidentiality and does not decide the parties’ underlying claims or defenses.

The detailed version

For law students, journalists, and other readers who want the full reasoning

Case
Massachusetts Mutual Life Insurance Company v. Bellini · No. 7:20-cv-00733
Judge
Paul Davison
Date
Sept. 16, 2020

Nature of the Order

The parties submitted, and the court ordered, a stipulated protective order under Federal Rule of Civil Procedure 26(c). The order governs confidential documents and information exchanged in discovery in this litigation. It is a discovery-management order, not a decision on the merits of the underlying dispute.

What Counts as Confidential

A producing party, person, or entity may designate material as “Confidential” only when the material is entitled to protection under applicable law and the designation is made in good faith. Protected health information covered by the Health Insurance Portability and Accountability Act, patient files and related medical records, tax returns, and underwriting manuals or claim-handling guidelines are treated as confidential without requiring additional marking. The order allows those designations to be challenged.

Other confidential material generally must be marked “CONFIDENTIAL” on the document and on each page containing protected information. A party may also designate material produced by another party or a nonparty by giving written notice within 14 days after receiving the production and identifying the reasons for confidentiality.

Disclosure and Use Restrictions

Confidential information may be disclosed to the parties, their counsel and counsel’s personnel, identified authors or recipients, court personnel, mediators, arbitrators, and other people agreed upon by the parties. It may also be disclosed to court-designated people, witnesses or potential witnesses, experts and consultants, and certain service providers when reasonably necessary for the litigation. Those additional recipients must first sign the confidentiality agreement attached as Exhibit A.

People receiving confidential material may use it only for this litigation, including later proceedings such as an appeal. The order also requires notice when a person covered by the order receives outside legal process seeking confidential information and generally requires a 10-day period before disclosure so the designating party can seek protection.

Challenges and Court Filings

A party challenging a confidentiality designation must give written notice explaining why the material is not entitled to confidential treatment. The designating party has 14 days to respond, after which the parties must try to resolve the dispute. If they cannot agree, they must use the dispute procedures in the court’s discovery order. The material remains confidential until the parties consent to a change or the court orders one.

The order does not decide whether confidential material is relevant, discoverable, or admissible. Confidential material used in a deposition may be subject to additional designation procedures, and protected portions of court filings must be handled under the Southern District of New York’s electronic filing rules. Only portions containing confidential information should be filed under seal, and parties may ask the court for additional protections at a hearing or trial.

Health Information and End of the Litigation

The order treats protected health information as covered by a qualified protective order under HIPAA. The parties may not use or disclose that information for purposes outside the litigation. At the end of the litigation, protected health information must be returned to the covered entity or destroyed with a sworn verification of destruction, but original protected health information may not be destroyed and must be returned.

The protective obligations continue after the litigation ends. Within 120 days after final conclusion of all aspects of the litigation, including appeals, confidential documents and copies generally must be returned or destroyed, subject to the order’s provisions concerning counsel’s work product and MassMutual’s legal and regulatory retention obligations. The order also extends its protections to documents and information produced by nonparties under subpoenas.

The authoritative version

Read the full 13-page opinion on CourtListener, the free public archive maintained by the Free Law Project.

Open opinion PDF →
Summary written with AI assistance. See how summaries are made. Spot something wrong? Tell us.